Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search a test
Simple search

Simple search

*
(*) mandatory field


 

29 Result(s)

Result(s)sorted by
Speciality(ies)/objective(s)
(29)
(2)
(1)
(1)
Technique(s)
(4)
Purpose(s)
(29)
(23)
Quality management
(16)
(17)
Country(ies)
(1)
(13)
(8)
(2)
(1)
(1)
(2)
(1)
RESET
Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
    • Medizinisch Genetisches Zentrum München
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Analysis of susceptibility for narcolepsy (HLA-DQB1*15, HLA-DRB1*06)
    • The Doctors Laboratory Ltd
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 and HLA-DRB1 genotyping)
    • CHRU de Lille - Centre de Biologie Pathologie Génétique
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics, Immunology
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Accreditation
    • Molecular diagnosis of susceptibility to diseases linked to HLA class II (HLA-DQB1, HLA-DRB1)
    • Biomnis
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • IVRY SUR SEINE
    • Accreditation
    • Molecular diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes)
    • EFS Rhône-Alpes
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Accreditation
    • Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of predisposition to narcolepsy-cataplexy (HLA-DQB1 gene)
    • CHU Paris - Hôpital Robert Debré
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Accreditation
    • Molecular diagnosis of narcolepsy (HCRT gene)
    • CeGaT GmbH
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
    • Laboratoire Cerba
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Analysis of susceptibility for narcolepsy (HLA-DQ, HLA-DR)
    • Ruhr-Universität Bochum
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BAD OEYNHAUSEN
    • Accreditation
    • Analysis of susceptibility for narcolepsy (HLA-DQA1, HLA-DQB1 genes)
    • Finnish Red Cross Blood Service
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FINLAND
    • Finland
    • HELSINKI
    • Accreditation
    • HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
    • Labor Prof. Dr. G. Enders MVZ
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Accreditation
    • Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (HLA-DQB1 gene)
    • Hôpitaux Universitaires de Genève HUG
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Molecular diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes: PCR-SSO)
    • EFS Rhône Alpes - Grenoble
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • RHONE-ALPES
    • LA TRONCHE
    • Accreditation
    • Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping by sequencing)
    • EFS Bretagne
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • BRETAGNE
    • RENNES
    • Accreditation
    • Molecular diagnosis of Narcolepsy: complete sequencing of HCRT gene
    • Universität Zürich
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • SCHLIEREN
    • Molecular diagnosis of susceptibilty to narcolepsy with cataplexy (HLA-DQB1 gene)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (haplotypes DQB1*0602+DRB1*1501)
    • IMEGEN - Instituto de Medicina Genómica
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Analysis of susceptibility for narcolepsy (HLA-DQB1, HCRT, MOG genes)
    • Gemeinschaftspraxis für Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of suceptibility to narcolepsy (HLA-DQA1, HLA-DQB1 genes)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of susceptibility to narcolepsy (HAL-DQB1 gene)
    • USL4 - Nuovo Ospedale Santo Stefano
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • TOSCANA
    • PRATO
    • Molecular diagnosis of susceptibility to narcolepsy (HLA-DQB1 gene)
    • Établissement Français du Sang Alpes-Méditerranée
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Analysis of susceptibility for Narcolepsy-cataplexy and Narcolepsy without cataplexy (HLA-DQB1 and HLA-DRB1 gene)
    • Laboratório de Análises Clínicas Dr. Joaquim Chaves
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • CENTRO
    • OEIRAS
    • Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene ; PCR-SSO)
    • CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : PCR based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of predisposition to narcolepsy-cataplexy (HLA-DQB1 gene)
    • CHU de Reims - Hôpital Robert Debré
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
    • Humangenetische Praxis Dr. Schmidt & Mautner
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Molecular diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 and HLA-DRB1 genotyping)
    • CHU de Nice - Hôpital l'Archet 1
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • NICE
    • Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
    • CHU de Bordeaux-GH Pellegrin
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX